Jaeduk Yoshimura Noh Selected Research

thyrotropin-binding inhibitory immunoglobulin

6/2021	Clinical Course of Euthyroid Subjects With Positive TSH Receptor Antibody: How Often Does Graves' Disease Develop?
10/2020	TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease.
1/2016	TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
1/2011	Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaeduk Yoshimura Noh Research Topics

Disease

12	Graves Disease (Basedow Disease) 01/2022 - 11/2008
6	Hyperthyroidism 01/2022 - 10/2005
3	Thyroiditis 01/2011 - 10/2005
2	Thyrotoxicosis 11/2021 - 10/2005
2	Hypothyroidism 10/2020 - 03/2008
2	Graves Ophthalmopathy 01/2016 - 01/2015
1	Myocardial Infarction 11/2021
1	Disease Progression 06/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2021
1	Earache (Otalgia) 02/2021
1	Rare Diseases (Rare Disease) 02/2021
1	Meningitis 02/2021
1	Otitis Media 02/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2021
1	Hearing Loss (Hearing Impairment) 02/2021
1	Familial Dysalbuminemic Hyperthyroxinemia 02/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2016
1	Papillary Carcinoma 01/2015
1	Inflammation (Inflammations) 01/2011
1	Atrophy 03/2008

Drug/Important Bio-Agent (IBA)

5	Thyrotropin Receptors (Thyrotropin Receptor)IBA 06/2021 - 11/2008
4	thyrotropin-binding inhibitory immunoglobulinIBA 06/2021 - 01/2011
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2020 - 02/2017
2	AntibodiesIBA 01/2019 - 01/2011
2	Troleandomycin (TAO)FDA Link 01/2015 - 01/2011
2	Thyroxine (Levothyroxine)FDA LinkGeneric 03/2008 - 10/2005
1	Methimazole (Thiamazole)FDA LinkGeneric 01/2022
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	TroponinIBA 11/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2021
1	Propylthiouracil FDA Link 02/2021
1	IodineIBA 10/2020
1	dimemorfan (AT 17)IBA 10/2020
1	Potassium Iodide (Pima)FDA Link 06/2020
1	GlucocorticoidsIBA 01/2011
1	Long-Acting Thyroid Stimulator (LATS)IBA 01/2011
1	AutoantibodiesIBA 11/2008
1	thyroid stimulation-blocking antibodyIBA 03/2008
1	Thyroglobulin FDA Link 03/2008
1	Iodide Peroxidase (Deiodinase)IBA 03/2008
1	Indicators and Reagents (Reagents)IBA 10/2005
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 10/2005

Therapy/Procedure

6	Therapeutics 01/2022 - 03/2008
1	Treatment Delay 02/2021
1	Renal Dialysis (Hemodialysis) 01/2016
1	Thyroidectomy 01/2015